Vitamin supplementation delayed disease progression in asymptomatic HIV-infected people in Botswana.
The WHO now recommends that all HIV-infected people with a CD4 count <500 cells/mm3 receive antiretroviral therapy (ART). That goal is currently difficult to achieve, so alternative strategies to delay disease progression are needed. Given that micronutrient deficiency occurs early in the course of HIV infection, U.S. investigators randomized 878 ART-naive adults in Botswana with HIV subtype C and early disease (defined as a CD4 count >350 cells/mm3) to receive placebo, only multivitamins (B vitamins plus C and E), only selenium, or multivitamins plus selenium as a single pill. At baseline, the median CD4 count was 420 cells/mm3 (33% had a count ≥500 cells/mm3), and the median viral load was 4.14 log10 copies/mL.
During a median 2 years of f…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)